Condition
Chronic Nephropathy
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 3 (1)
P 4 (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00199927Phase 3CompletedPrimary
Statins in Proteinuric Nephropathies
NCT00861731Phase 4Unknown
Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
NCT00276133Phase 4CompletedPrimary
Effects of Atorvastatin Versus Probucol on Small Dense LDL
NCT00298129Completed
Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease
Showing all 4 trials